Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Paracetamol + ondansetron is a combination medication that pairs an analgesic/antipyretic (paracetamol/acetaminophen) with an antiemetic (ondansetron). This combination is used to prevent and manage nausea and vomiting caused by surgery, cancer chemotherapy, and radiation therapy, while also providing relief from mild to moderate pain including headaches, muscle aches, menstrual cramps, toothaches, and backaches. Ondansetron works by blocking serotonin (5-HT3) receptors, which can induce nausea and vomiting, while paracetamol reduces the production of prostaglandins, substances in the body that cause pain and fever.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on paracetamol + ondansetron.